Skip to main content

Type 1 Diabetes News

Type 1 Diabetes is a chronic condition in which your body loses the ability to produce insulin, which is necessary for most cells to convert food into energy and regulate blood sugar levels. 

As health care spending becomes an increasing concern, the cost associated with chronic disease – particularly diabetes – is becoming an important issue to consider. A...
CVS recently announced the introduction of new monitoring services for people with diabetes offered through its MinuteClinic walk-in healthcare clinics. Dubbed...
Will CGM be for the masses or just the highly motivated? See Jim Hirsch's thoughts on the matter.
Medtronic’s new Enlite sensor appears to be a big step forward from the currently available Sof-Sensor shown above (bottom right). Medtronic held its first “hands-on”...
The proud winners of our recent Willie Mays giveaway recap their grand prize trip to San Francisco.
Novo Nordisk continues to make headway in the development of Degludec and DegludecPlus, the company’s two new “next-generation” insulins. The company recently announced...
Curious about Medtronic’s Enlite sensor? Nikos Filippou discusses his experience with the new product.
Amylin and JDRF will be looking into the possibility of combining Symlin and insulin into one injection. Earlier this month, Amylin and JDRF entered a partnership to...
(S)he said what?!?
Our top takeaways from the European Association for the Study of Diabetes meeting in Stockholm, and The Obesity Society meeting in San Diego.
Although no one ever said insulin pump management was easy, we’re very happy that new tools are emerging that can make pumping easier and better. We have often wondered...
We were heartened this year by World Diabetes Day, which officially recognizes the growing epidemics of diabetes, diabetes complications, and obesity. Every year on...
Testing blood sugar levels day in and day out isn't always fun for kids. But what if they were rewarded with points for each test that was within range and also for...
Kerri Morrone Sparling gives her take on the pros and cons of CGM.
Bayer presented an interactive overview of its CGM product in development, which has a number of features that the company says will make it easier to use than current...
June and July have been very busy months in the diabetes world...
We had a great time at AADE learning more about what DexCom has in the works—primarily this relates to work toward FDA approval for its fourth-generation continuous...
Puzzled by the recent FDA decisions? Dr. Sanjay Kaul discusses the regulatory environment for diabetes and obesity medications.
In a recent study, Novo Nordisk's next-generation basal insulin degludec was found to cause less hypoglycemia than Lantus. In early May, Novo Nordisk announced the...
Powerhouse AADE Educator of the Year Elaine Massaro emphasizes the importance of behavior change and how to do it.

Pages